Tweet Archive for hashtag “#Merz” « page 5

Introduction of the Microdroplet Technique with BoNTA INC for crow’s feet treatment
ncbi.nlm.nih.gov/pubmed/23888258 #Xeomin #Bocouture #Merz

9:18am Jul 30 2013 —

Immune response and Botox – another ref from PubMed ncbi.nlm.nih.gov/pubmed/8232357 #Allergan #Galderma #Merz #Ipsen @MailOnline

8:13am Jul 18 2013 —

Immune response and Botox – need more investigation: what I found on PubMed ncbi.nlm.nih.gov/pubmed/22385115 #Allergan #Galderma #Merz #Ipsen

8:11am Jul 18 2013 —

Info or Intox! Women becoming immune to Botox? dailymail.co.uk/femail/article…
Scientific community should answer #Allergan #Galderma #Merz #Ipsen

8:06am Jul 18 2013 —

IBoNT-A characteristics & management of glabellar frown lines ncbi.nlm.nih.gov/pubmed/23516136 #CosmeticDermatology #Xeomin #Xeomeen #Bocouture #Merz

11:31am Jul 11 2013 —

IncobotulinumtoxinA in Esthetics ncbi.nlm.nih.gov/pubmed/23839200 #CosmeticDermatology #Xeomin #Xeomeen #Bocouture #Merz

11:28am Jul 11 2013 —

System’s failure: Early granulomatous foreign body reactions to a novel alginate dermal filler ncbi.nlm.nih.gov/pubmed/21929551 #DermalFillers #Merz

8:56am Jul 3 2013 —

Emerging fillers hint at innovations in treating volume loss dermatologytimes.modernmedicine.com/dermatology-ti… #DermalFillers #Allergan #Galderma #Merz

8:46am Jul 1 2013 —

IBoNT-A in Esthetics jddonline.com/articles/derma… #Merz #Xeomin #Xeomeen #Bocouture #CosmeticDdermatology

5:12am Jun 26 2013 —

1st of its kind: systematic rev & meta-analyses of 3 facial rhytides BoNT-A ncbi.nlm.nih.gov/pubmed/23763852 #Allergan #Galderma #Merz #Ipsen #Valeant

1:10am Jun 24 2013 —